Genmab — Investor Relations & Filings
Filings indexed
2,819
across all filing types
Latest filing
2022-02-16
Annual Report
Country
DK
Denmark
Listing
CO
GMAB
Genmab is an international biotechnology company that specializes in the creation, development, and commercialization of differentiated antibody therapeutics. The company focuses on transforming the treatment of cancer and other serious diseases. By utilizing proprietary antibody technology platforms and scientific expertise, Genmab develops a pipeline of innovative medicines. Its activities span from discovery and research through clinical development to deliver novel therapies to patients.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 20-F | 2022-02-16 | English | |
| 6-K | 2022-02-16 | English | |
| Report Publication Announcement 2022 | 2022-02-16 | English | |
| Genmab Publishes 2021 Annual Report | 2022-02-16 | English | |
| Genmab Publishes 2021 Annual Report | 2022-02-16 | Danish | |
| 6-K | 2022-02-03 | English |
Browse filings by year
20 years- 2026 64 filings
- 2025 190 filings
- 2024 204 filings
- 2023 149 filings
- 2022 190 filings
- 2021 226 filings
- 2020 167 filings
- 2019 213 filings
- 2018 68 filings
- 2017 124 filings
- 2016 229 filings
- 2015 128 filings
- 2014 107 filings
- 2013 132 filings
- 2012 98 filings
- 2011 97 filings
- 2010 133 filings
- 2009 121 filings
- 2008 109 filings
- 2007 70 filings
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2022
15 filings
| |||||
| 12210885 | 20-F | 2022-02-16 | English | ||
| 12210886 | 6-K | 2022-02-16 | English | ||
| 1419782 | Report Publication Announcement 2022 | 2022-02-16 | English | ||
| 12552215 | Genmab Publishes 2021 Annual Report | 2022-02-16 | English | ||
| 12552214 | Genmab Publishes 2021 Annual Report | 2022-02-16 | Danish | ||
| 12210887 | 6-K | 2022-02-03 | English | ||
| 12210889 | Major Shareholding Notification 2022 | 2022-02-03 | English | ||
| 12210888 | 6-K | 2022-01-26 | English | ||
| 1421740 | Director's Dealing 2022 | 2022-01-26 | English | ||
| 12553129 | Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons | 2022-01-26 | English | ||
| 12210890 | 6-K | 2022-01-25 | English | ||
| 12210891 | 6-K | 2022-01-25 | English | ||
| 1421834 | Earnings Release 2021 | 2022-01-25 | English | ||
| 12553205 | Genmab Announces Net Sales of DARZALEX® (daratumumab) for 2021 | 2022-01-25 | English | ||
| 12210892 | 6-K | 2022-01-04 | English | ||
Financials
Loading financials…
We couldn't load the financials
No data available yet
We have extracted financials for Genmab, but not for this combination of statement and period. Try a different combination.
Swipe the table to view all periods, or rotate your phone for a wider view.
| Line item | ! |
|---|---|
| Definition not yet available — coming soon. |
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Genmab via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/3365/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=3365 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=3365 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=3365 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 3365}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Genmab (id: 3365)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.